Clinical trial
A Study for the Neoadjuvant Treatment of Breast Cancer
NCT05420454
Study timeline
Study start (estimated)2022-07-10Date precision: day
Registry last updated2022-07-01
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
DocetaxelDRUG · verified · RxNorm: docetaxel
CarboplatinDRUG · verified · RxNorm: carboplatin
TrastuzumabDRUG · verified · RxNorm: trastuzumab
PertuzumabDRUG · verified · RxNorm: pertuzumab
Nab paclitaxelDRUG
EpirubicinDRUG · verified · RxNorm: epirubicin
CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
DocetaxelDRUG · verified · RxNorm: docetaxel
EpirubicinDRUG · verified · RxNorm: epirubicin
CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
Nab paclitaxelDRUG
Sponsors & collaborators
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05420454 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.